Delivery Order SPE2DB25D3005-SPE2DB25FQEFQ

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,476.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The $6,025.68 firm fixed-price delivery order contract has a performance period extending through May 15, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This contract is part of a larger $999,999,999.00...
This federal contract award, valued at $14,247.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a medication, with a performance period ending on May 15, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $5,749.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a completion date of February 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $59,269.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the provision of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a performance period extending through May 2025. The contract has a firm fixed-price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,299.57, is a Firm Fixed Price Delivery Order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medical products. The contract has an ultimate completion date of March 25, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor on this award, which is part of a...
This federal contract award, valued at $2,643.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, and has a completion date of February 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $11,110.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. The contract has an ultimate completion date of July 28, 2023 and is a firm fixed-price agreement. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $14,191.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a completion date of March 24, 2025. This appears to be a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $8,861.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, and has a completion date of May 22, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQEFQ
    Delivery Order

This federal contract award, valued at $5,287.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA PEN 40 MG/0.8 MLS. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables Amerisourcebergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/15/25, 4:02 PM